Printer Friendly

Articles from M2 Pharma (March 7, 2016)

1-16 out of 16 article(s)
Title Author Type Words
AbbVie passes US FDA approval for IMBRUVICA (ibrutinib) for first-line treatment for patients with chronic lymphocytic leukemia. 253
Amarantus BioScience appoints new member to strategic advisory board. 185
Astellas names new senior vice president and head of Marketing Strategy. 153
BioPharmX starts phase 2a clinical study for BPX-01. Clinical report 188
Cesca Therapeutics reports one for 20 reverse common stock split. 154
Elekta's Leksell Gamma Knife Icon Radiosurgery System Makes US Clinical Debut. 183
First Patients Enrolled in New Study to Expand Indication for NeoTract's UroLift System. 384
Hitachi, Redlen Technologies Team on Next Generation Medical Photon Counting CT System Development. 385
Otonomy commences Otiprio phase two clinical trial. 204
Syneron Medical, Allergan Forge US Aesthetics Collaboration. 272
Ulrich Medical USA Releases the uNion Cervical Plate System in Spinal Implant Product Portfolio Expansion. 157
US FDA Clears BioPhotas CellumaEsthetic Device for Wrinkle Treatment. 211
Varian Medical Systems Plans Brazil Cancer Treatment Education and Training Collaborations. 223
Vaxart commences preclinical testing of Zika virus oral vaccine. 195
Zimmer Biomet enters into exclusive global distribution agreement with CelgenTek Innovations for unique fracture fixation and void-filling solution. 191
Zimmer Biomet, CelgenTek Innovations Ink Global Distribution Agreement. 288

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters